Trademark Details For GOSEMDA (Serial Number 97774850)

  •  Home
  •  Print
GOSEMDA
1
3
2
0
word.basic_information
Serial Number  United States - USPTO 97774850
Registration Number -
Mark
GOSEMDA
Filing Date Jan-31-2023
Status
Pending  
THIRD EXTENS.. (732)
THIRD EXTENSION - GRANTED
Attorney Name
TTAB
0
Action Tags
  


  • TEVA PHARMACEUTICALS USA


005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active





Correspondences

NameLaurence Rickles TEVA PHARMACEUTICALS USA, INC.
Address400 INTERPACE PARKWAY BUILDING A PARSIPPANY, NJ 07054 United States

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Feb-03-2023NEW APPLICATION ENTERED   NWAPI
Feb-17-2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Oct-30-2023ASSIGNED TO EXAMINER   DOCKD
Oct-30-2023EXAMINERS AMENDMENT -WRITTEN   CNEAR
Oct-30-2023EXAMINERS AMENDMENT E-MAILED   GNEAF
Oct-30-2023
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  
GNENO
Oct-30-2023EXAMINER'S AMENDMENT ENTERED   XAECI
Oct-30-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Nov-15-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Dec-05-2023PUBLISHED FOR OPPOSITION   PUBOA
Dec-05-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jan-30-2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Jul-24-2024SOU TEAS EXTENSION RECEIVED   EEXTI
Jul-24-2024SOU EXTENSION 1 FILED   EXT1S
Jul-24-2024SOU EXTENSION 1 GRANTED   EX1GS
Jul-24-2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Jan-08-2025SOU TEAS EXTENSION RECEIVED   EEXTI
Jan-08-2025SOU EXTENSION 2 FILED   EXT2S
Jan-08-2025SOU EXTENSION 2 GRANTED   EX2GS
Jan-08-2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Jul-01-2025SOU TEAS EXTENSION RECEIVED   EEXTI
Jul-01-2025SOU EXTENSION 3 FILED   EXT3S
Jul-01-2025SOU EXTENSION 3 GRANTED   EX3GS
Jul-02-2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED   EXRAE
Nov-06-2025ASSIGNED TO EXAMINER   DOCKD